title: When to initiate treatment with radium-223 in patients with metastatic castration-resistant prostate cancer.
authors.affiliation: Atlantic Urology Clinics, Myrtle Beach, South Carolina.
authors.forename: Neal D
authors.initials: ND
authors.lastname: Shore
mesh_terms: D014408:Biomarkers, Tumor; D001859:Bone Neoplasms / Q000556:secondary; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D011379:Prognosis; D064129:Prostatic Neoplasms, Castration-Resistant / Q000401:mortality / Q000473:pathology* / Q000532:radiotherapy*; D011868:Radioisotopes / Q000627:therapeutic use*; D011883:Radium; D061665:Time-to-Treatment; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor; D011868:Radioisotopes; D011883:Radium